Moderna’s mRNA Flu Shot Linked to Surge in Severe Adverse Events, VAERS Data Shows

A new mRNA influenza vaccine from Moderna, approved by the U.S. Food and Drug Administration (FDA) on August 5, has already been linked to 78 reports of adverse events in a federal safety monitoring system.

MFLUSIVA is reportedly a vaccine for active immunization against influenza caused by virus subtypes A and B contained in the vaccine.

But does the vaccine present a greater threat than the influenza it aims to prevent? Reports filed in the Vaccine Adverse Event Reporting System (VAERS) through late October document instances of sudden mobility loss, partial vision impairment, cardiac arrhythmia, syncope, and hospitalization.

BREAKING: Reports of serious injuries and disabilities with Moderna’s new mRNA flu shot have begun to FLOOD the CDC’s Vaccine Adverse Event Reporting System.

Among them are accounts of sudden inability to walk, partial vision loss, cardiac arrhythmias, fainting, and hospitalization.

This hazardous gene therapy should NEVER have been approved.

Here are some of the most concerning cases:

71-year-old woman: Reportedly lost the use of her legs following vaccination.

71-year-old man: Unable to stand or walk approximately 17 hours after vaccination. Remained on the floor for about an hour.

74-year-old woman: Partial vision loss in both eyes, severe headache, fever, and weakness.

Keep reading

Unknown's avatar

Author: HP McLovincraft

Seeker of rabbit holes. Pessimist. Libertine. Contrarian. Your huckleberry. Possibly true tales of sanity-blasting horror also known as abject reality. Prepare yourself. Veteran of a thousand psychic wars. I have seen the fnords. Deplatformed on Tumblr and Twitter.

Leave a Reply